AM

Amarin

AMRN
NASDAQHealth Care

Recent Patents

amrn
almost 2 years ago

Filed a patent for "compositions and methods for treating and/or preventing cardiovascular disease" on Thu, July 4, 2024

New US Patent
amrn
almost 2 years ago

Filed a patent for "methods of reducing risks of cardiovascular events in subjects with low baseline epa:aa ratio" on Thu, November 10, 2022

New US Patent
amrn
almost 2 years ago

Filed a patent for "pharmaceutical composition comprising eicosapentaenoic acid and derivatives thereof and a statin" on Thu, January 18, 2024

New US Patent
amrn
almost 2 years ago

Filed a patent for "lymph-releasing compositions of fatty acids and uses thereof for lymphatic incorporation and systemic disease treatment" on Thu, January 26, 2023

New US Patent
amrn
almost 2 years ago

Filed a patent for "pharmaceutical composition comprising eicosapentaenoic acid and nicotinic acid and methods of using same" on Thu, January 25, 2024

New US Patent
amrn
almost 2 years ago

Filed a patent for "co-administration of atorvastatin and ethyl eicosapentaenoic acid or a derivative thereof" on Thu, October 5, 2023

New US Patent
amrn
almost 2 years ago

Filed a patent for "methods of treating hypertriglyceridemia" on Thu, January 25, 2024

New US Patent
amrn
almost 2 years ago

Filed a patent for "methods of reducing the risk of a cardiovascular event in a subject on statin therapy" on Thu, October 26, 2023

New US Patent
amrn
almost 2 years ago

Filed a patent for "stable pharmaceutical composition and methods of using same" on Thu, May 9, 2024

New US Patent
amrn
almost 2 years ago

Filed a patent for "lymph-releasing compositions of fatty acids and uses thereof for lymphatic incorporation and systemic disease treatment" on Thu, May 23, 2024

New US Patent
amrn
almost 2 years ago

Filed a patent for "compositions comprising epa and methods of using the same for treating and/or preventing endothelial dysfunction in a subject" on Thu, May 30, 2024

New US Patent
amrn
2 years ago

Filed a patent for "methods of reducing the risk of cardiovascular events in a subject" on Thu, April 6, 2023

New US Patent
amrn
2 years ago

Filed a patent for "methods of reducing the risk of heart failure" on Thu, November 3, 2022

New US Patent
amrn
2 years ago

Filed a patent for "methods of treating mixed dyslipidemia" on Thu, August 4, 2022

New US Patent
amrn
2 years ago

Filed a patent for "methods of treating hypertriglyceridemia" on Thu, October 13, 2022

New US Patent
amrn
2 years ago

Filed a patent for "methods of treating hypertriglyceridemia" on Fri, July 1, 2022

New US Patent
amrn
2 years ago

Filed a patent for "co-administration of atorvastatin and ethyl eicosapentaenoic acid or a derivative thereof" on Mon, July 11, 2022

New US Patent
amrn
2 years ago

Filed a patent for "compositions and methods for lowering triglycerides" on Thu, July 6, 2023

New US Patent
amrn
2 years ago

Filed a patent for "compositions and methods for lowering triglycerides in a subject with reduced kidney function and diabetes mellitus" on Thu, August 10, 2023

New US Patent
Cashu Markets
Cashu
Markets

By Cashu Markets. Providing market news, analysis, and research for investors worldwide.

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Markets is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Markets is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Markets and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Cashu Markets
Cashu
Markets

Setting up your session...